OpenAI has reportedly met with officials from the U.S. Food and Drug Administration (FDA) to discuss the use of artificial ...

Software giant Microsoft and artificial intelligence firm OpenAI have reportedly entered talks to renegotiate their ...

The FDA has started exploring how AI can be used to accelerate drug approvals in collaboration with OpenAI amid oversight ...

The AI moved the cake (which had been barely visible behind the paper towel roll in the original still) to be the focal point ...

OpenAI and Microsoft Corp. are revising the terms of their partnership that will enable the ChatGPT maker to go public at a future date while preserving the software giant’s access to artificial ...

Google's antitrust trial, like Microsoft's, may have inadvertently spurred innovation by competitors, challenging its search ...